Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Nutrition - The Untold Story

A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?

Abbott Laboratories' recent stock price dip contrasts with its strong Medical Devices division, creating a noteworthy opportunity for dividend investors.

MarketBeat

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

Barchart

Is Abbott’s January Pullback a Good Time to Buy?

Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its business and driving cash flow.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Garmin just built its own version of MyFitnessPal inside Garmin Connect and it could change how you train

Garmin’s new Nutrition feature brings calorie and macro tracking directly into Garmin Connect

Is Archer-Daniels-Midland Stock Underperforming the Nasdaq?

As Archer-Daniels-Midland has underperformed relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Reckitt sees sales slide after £100m tornado hit to baby formula

The Nurofen-to-Dettol maker saw revenues dragged lower by a 17.4% tumble in sales at its nutrition division caused by tornado damage to a warehouse.

Evening Standard

A big idea for small farms: How to link agriculture, nutrition and public health

In Boulder, Colo., the county is investing in sustainable farming and helping people buy local produce. It's been called "a triple win" – for customers, farmers and the economy.

WEKU

Read news from The Economist, FT, and more,
with one subscription

People Are Using ChatGPT for Nutrition Advice — The Results Are Dangerous

When it comes to nutrition and diet, there’s a lot of information on the internet that may not be scientifically valid or applicable for humans.

Inverse

Ready to run: Assessing protein needs for performance

As you train for your upcoming distance race or other athletic event, you may be looking for ways to fine-tune your program and up your performance. Now's the time to take another look at what you're eating since nutrition is a key component of your training plan.

Tribune News Service

Lawmakers steer toward food stamp clash on work requirements

WASHINGTON — Lawmakers, as they work on the 2023 farm bill, are staking out positions on nutrition and food stamps — the Agriculture Department’s biggest single program and a perennial source of contention.

Tribune News Service

Lawmakers steer toward food stamp clash on work requirements - Roll Call

Food stamps are on course again to be a flash point in the farm bill as some Republicans want to add work requirements for recipients.

Roll Call

Planning to Retire in 10 Years? Buy This Stock Now

With an end to market volatility nowhere in sight, the strong fundamentals, stable prospects, and consistent income-generation potential of Archer-Daniels-Midland (ADM) merit its place in investors’ retirement portfolios. Read on….

StockNews.com

Cauliflower: A versatile nutrition superstar

Like many consumers, you may be on a quest for healthier food options and willing to try something new or a new take on a familiar food. If you're diagnosed with celiac disease, you may be looking for gluten-free alternatives. Or maybe you're on the hunt for lower carbohydrate choices.

Tribune News Service

Archer-Daniels-Midland Q1 Earnings Surpass Estimates

Archer-Daniels-Midland Co (NYSE:ADM) reported first-quarter FY22 sales growth of 25.2% year-on-year to $23.65 billion, beating the consensus of $17.91 billion. Revenues from Ag Services and Oilseeds rose 21.6% Y/Y, Carbohydrate Solutions increased 51.4%, and Nutrition climbed 23%. The gross profit increased 22.5% Y/Y to $1.9 billion with a margin of 8%. The Segment…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What Does Raymond James, Wells Fargo Have To Say On Abbott's Q1 Earnings

Raymond James thinks Abbott Laboratories' (NYSE: ABT) 1Q results were solid and demonstrated the durable nature of ABT's portfolio, as three out of four business segments grew over 10% organically, with Nutrition growing 8%

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.